Portfolio News

Aramco Venture Arm Investing in U.S. Startup Wasabi

The venture capital arm of Saudi Arabia’s state-owned energy producer Aramco is investing in Boston-area cloud-storage startup Wasabi Technologies. One of Aramco’s funds, Prosperity7 Ventures, is contributing to a $25 million follow-on investment, alongside the venture capital arm of disk-drive maker Western Digital Corp., Wasabi Chief Executive Officer David Friend said exclusively in a Bloomberg Radio interview Wednesday. Read more >>
Read more...

Zylö and Amifar Laboratorios Forge Broad-Ranging Partnership

Zylö Therapeutics Inc., developer of the transformational Z-pod™ topical delivery platform, announced that it has entered into a broad-ranging agreement with Amifar Laboratorios Spain to supply Z-pods to further enhance Amifar’s new line of advanced cosmetics. Amifar and Zylö have initiated a product development collaboration beginning with two actives and have plans to expand the list of actives over time. Read more >>
Read more...

RevBio Receives a $2 Million NIH Grant to Pursue the Treatment of Wrist Fractures with Its Innovative Bone Adhesive Technology

RevBio, Inc., announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant expected to total $2 million over two years from the National Institute on Aging, part of the National Institutes of Health. This funding will allow the company to pursue the treatment of wrist fractures with its patented bone adhesive technology known as Tetranite®. Read more >>
Read more...

Sealing the Deal – Using Bone Glue to Treat Pain from Wisdom-Tooth Extractions

For many teens, having one or more wisdom teeth removed is a health milestone after the first third molar teeth come in at the very back of the mouth and there isn’t enough room for them. But with this milestone also often comes another one – their first exposure to opioids. “Of about 10 million wisdom-tooth extractions done in a year, about a third come with a prescription for an opioid,” says George Kay, D.M.D., Chief Scientific Officer at the...
Read more...

RevBio Enters the Animal Health Market to Help Improve Canine Dental Care

As its first veterinary application, RevBio, Inc. announced that it has initiated a clinical study to validate the use of its innovative bone adhesive biomaterial to fill tooth extraction sockets in dogs in order to improve healing, maintain and support jaw thickness, and restore the structural stability which may help resist potential mandibular fractures. Read more >>
Read more...

Indoor Air Quality Takes Center Stage During Building Reopening

For building owners and facilities managers, indoor air quality (IAQ) is taking center stage as they plan for safe reopening of workplaces in 2021. IAQ solutions can help reduce the likelihood of airborne disease transmission. New offerings from Honeywell and as a service vendor Aircuity are poised for growth in the IAQ market... Aircuity monitors many IAQ parameters and designs custom solutions, which are funded through savings from an organization's operational and energy...Read more >>
Read more...

Corbus Pharmaceuticals Announces Presentations at the New York Academy of Sciences Webinar on Targeting the Endocannabinoid System to Treat Human Diseases

Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced it will participate in the New York Academy of Sciences' webinar on January 27, 2021 on the endocannabinoid system as a target for therapeutic agents. Read more >>
Read more...